Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States

Journal article

Peer reviewed

Jacques Simkins, Ji Fan, Jose F Camargo, Laura Aragon and Corey Frederick

The Annals of pharmacotherapy, Vol.49(10), pp.1177-1178

2015-10

PMID: 26238469

Abstract

Bacteremia - microbiology

Administration, Intravenous

Liver Transplantation

Klebsiella Infections - drug therapy

Fosfomycin - administration & dosage

United States

Humans

Middle Aged

Bacteremia - drug therapy

Fatal Outcome

Anti-Bacterial Agents - administration & dosage

Klebsiella pneumoniae

46 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.23 Antibiotics & Antimicrobials; 1.23.146 Antibiotic Resistance
Web Of Science research areas: Pharmacology & Pharmacy
ESI research areas: Pharmacology & Toxicology

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States
Creators: Jacques Simkins
Ji Fan
Jose F Camargo
Laura Aragon
Corey Frederick
Publication Details: The Annals of pharmacotherapy, Vol.49(10), pp.1177-1178
Publisher: United States
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases
Language: English
Resource Type: Journal article
PMID: 26238469
Record Identifier: 991031576144802976